Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Infectivity in chimpanzees (Pan troglodytes) of plasma collected before HCV RNA detectability by FDA-licensed assays: implications for transfusion safety and HCV infection outcomes.

Busch MP, Murthy KK, Kleinman SH, Hirschkorn DF, Herring BL, Delwart EL, Racanelli V, Yoon JC, Rehermann B, Alter HJ.

Blood. 2012 Jun 28;119(26):6326-34. doi: 10.1182/blood-2011-12-393637. Epub 2012 Apr 12.

2.

Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission.

Katayama K, Kumagai J, Komiya Y, Mizui M, Yugi H, Kishimoto S, Yamanaka R, Tamatsukuri S, Tomoguri T, Miyakawa Y, Tanaka J, Yoshizawa H.

Intervirology. 2004;47(1):57-64.

PMID:
15044837
3.

Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia.

Bernardin F, Tobler L, Walsh I, Williams JD, Busch M, Delwart E.

Hepatology. 2008 May;47(5):1446-52. doi: 10.1002/hep.22184.

PMID:
18220272
4.

Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.

El Ekiaby M, Moftah F, Goubran H, van Drimmelen H, LaPerche S, Kleinman S, Busch M, Lelie N.

Transfusion. 2015 Jun;55(6):1186-94. doi: 10.1111/trf.13061. Epub 2015 Mar 13.

PMID:
25766141
5.

Transfusion transmission of HCV, a long but successful road map to safety.

Selvarajah S, Busch MP.

Antivir Ther. 2012;17(7 Pt B):1423-9. doi: 10.3851/IMP2459. Epub 2012 Dec 7. Review.

6.

Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.

Busch MP, Glynn SA, Wright DJ, Hirschkorn D, Laycock ME, McAuley J, Tu Y, Giachetti C, Gallarda J, Heitman J, Kleinman SH; National Heart, Lung, Blood Institute Nucleic Acid Test Study Group*..

Transfusion. 2005 Dec;45(12):1853-63.

PMID:
16371038
7.
8.

Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.

Galel SA, Strong DM, Tegtmeier GE, Holland PV, Kuramoto IK, Kemper M, Pietrelli L, Gallarda J.

Transfusion. 2002 Nov;42(11):1507-13.

PMID:
12421226
9.

The effect on the safety of intravenous immunoglobulin of testing plasma for antibody to hepatitis C.

Biswas RM, Nedjar S, Wilson LT, Mitchell FD, Snoy PJ, Finlayson JS, Tankersley DL.

Transfusion. 1994 Feb;34(2):100-4.

PMID:
7508642
10.

Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA.

Alter HJ, Sanchez-Pescador R, Urdea MS, Wilber JC, Lagier RJ, Di Bisceglie AM, Shih JW, Neuwald PD.

J Viral Hepat. 1995;2(3):121-32.

PMID:
7493306
11.

Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.

Weusten JJ, van Drimmelen HA, Lelie PN.

Transfusion. 2002 May;42(5):537-48.

PMID:
12084161
12.
13.

Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.

Bruhn R, Lelie N, Busch M, Kleinman S; International NAT Study Group..

Transfusion. 2015 Jun;55(6):1195-205. doi: 10.1111/trf.13024. Epub 2015 Feb 27.

PMID:
25727549
14.

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.

Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP; National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group..

N Engl J Med. 2004 Aug 19;351(8):760-8.

15.

Infectivity of hepatitis C virus in plasma after drying and storing at room temperature.

Kamili S, Krawczynski K, McCaustland K, Li X, Alter MJ.

Infect Control Hosp Epidemiol. 2007 May;28(5):519-24. Epub 2007 Apr 16.

PMID:
17464909
16.

Testing of corneoscleral discs and their culture media of seropositive donors for hepatitis B and C virus genomes.

Sengler U, Reinhard T, Adams O, Gerlich W, Sundmacher R.

Graefes Arch Clin Exp Ophthalmol. 2001 Oct;239(10):783-7.

PMID:
11760041
17.

Dynamics of viremia in early hepatitis C virus infection.

Glynn SA, Wright DJ, Kleinman SH, Hirschkorn D, Tu Y, Heldebrant C, Smith R, Giachetti C, Gallarda J, Busch MP.

Transfusion. 2005 Jun;45(6):994-1002.

PMID:
15934999
18.

Trace amounts of sporadically reappearing HCV RNA can cause infection.

Veerapu NS, Park SH, Tully DC, Allen TM, Rehermann B.

J Clin Invest. 2014 Aug;124(8):3469-78. doi: 10.1172/JCI73104. Epub 2014 Jul 8.

20.

Detection of hepatitis C virus core antigen for early diagnosis of hepatitis C virus infection in plasma donor in China.

Zhang HQ, Li SB, Wang GH, Chen K, Song XG, Feng XY.

World J Gastroenterol. 2007 May 21;13(19):2738-42.

Supplemental Content

Support Center